Ikoma Technologies Ltd.
Ikoma Technologies
₹ 0.00
0.00 (0.00)%
NSE
BSE
Capital Goods
Small-cap - With a market cap of ₹1.06 Cr.
| EX-Date | Purpose |
|---|---|
| 30 06 2021 | With reference to the intimation dated June 21, 2021, regarding Board meeting to be held on June 28, 2021, Good Value Irrigation Ltd has informed BSE that the meeting of the Board of director of the Company is rescheduled on June 30, 2021, to Consider and approve Audited Financial results for the quarter and year March 31, 2021. Further, reference to the Company s letter dated June 21, 2021, regarding intimation of closure of trading window, the trading window of company for the designated persons shall be remain closed till the expiry of 48 hours after the aforesaid results are made public. |
| 27 05 2022 | Good Value Irrigation Ltd has informed BSE regarding Board Meeting Intimation for Results & Closure of Trading Window. |
| 09 08 2022 | Quarterly Results |
| 26 09 2022 | Inter alia, to consider and approve :- 1. Appointment of Mr. Sandeep Kumar (DIN: 08284230) as an Additional Independent Director of the Company. 2. Any other matter with permission of the chair. |
| 10 11 2022 | Quarterly Results |
| 09 02 2023 | Quarterly Results |
| 26 05 2023 | Quarterly Results & Audited Results |
| 07 07 2023 | Preferential Issue of shares |
| 11 08 2023 | Quarterly Results |
| 22 09 2023 | Increase in Authorised Capital & Preferential Issue of shares & Inter alia, to consider and approve:- 1. Increase in authorised share capital of the company 2. To consider and issue and allotment of equity shares for consideration other than cash on the preferential basis in accordance with provisions of SEBI (LODR) Regulations, 2015. 3. To consider and approve the notice of postal ballot. 4. To consider and approve the appointment of scrutinizer in respect to conduct postal ballot process and scrutiny of postal ballot along with E-voting results. 5. To consider and discuss any other items as may be decided by the board of directors of the company. |
| 14 10 2023 | Scheme of Arrangement & Preferential Issue of shares Inter alia, to consider and approve the following matters(s): 1. To consider and increase the Authorised Share Capital of the company upto the amount as may be determined and approved by the Board. 2. To consider issue and allotment of Equity Shares at a price to be determined in accordance with the pricing formula prescribed under Chapter V of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 and other applicable rules, regulations and guidelines of SEBI and applicable provisions of Companies Act, 2013 for consideration other than cash on the preferential basis. 3. To consider and approved the Scheme of Arrangement with Vuenow Marketing Services Limited 4. To consider and approve the Notice of the Postal Ballot. 5. To consider and Approve the appointment of Scrutinizer in respect to conduct Postal Ballot process and scrutiny of Postal ballot voting along with E-Voting Results. 6. To Consider and discuss any other items as may be decided by the Board of Directors of the Company. |
| 21 10 2023 | Scheme of Arrangement (Revised) & Preferential Issue of shares Inter alia, to transact the following businesses as per the intimation Notice dated 10th October, 2023: 1. To consider and increase the Authorised Share Capital of the company upto the amount as may be determined and approved by the Board. 2. To consider issue and allotment of Equity Shares at a price to be determined in accordance with the pricing formula prescribed under Chapter V of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 and other applicable rules, regulations and guidelines of SEBI and applicable provisions of Companies Act, 2013 for consideration other than cash on the preferential basis. 3. To consider and approved the Scheme of Arrangement with Vuenow Marketing Services Limited 4. To consider and approve the Notice of the Postal Ballot. 5. To consider and Approve the appointment of Scrutinizer in respect to conduct Postal Ballot process and scrutiny of Postal ballot voting along with E-Voting Results. 6. To Consider and discuss any other items as may be decided by the Board |
| 26 10 2023 | Quarterly Results |
| 02 11 2023 | Quarterly Results |
| 13 02 2024 | Quarterly Results |
| 28 02 2024 | Inter alia, to consider and approve the following matters(s):- 1. To consider and approve the Scheme of Amalgamation with Vuenow Marketing Services Limited and Vuenow Infotech Private Limited 2. Consider and discuss any other items as may be decided by the Board of Directors of the Company. |
| 09 04 2024 | Interim Dividend Inter alia, to consider and approvethe following matters(s): 1. To consider, approve, and declare interim dividend for the Financial Year 2023-2024. 2. To fix the record date for payment of Interim Dividend. |
| 14 11 2024 | Quarterly Results(Cancelled) (Cancelled) |
| 20 11 2024 | Quarterly Results |
| 14 02 2025 | Quarterly Results |
| 14 02 2025 | Quarterly Results(Cancelled) (Cancelled) |
| 20 02 2025 | Quarterly Results(Cancelled) (Cancelled) |
| 20 02 2025 | Quarterly Results |
| 25 02 2025 | Quarterly Results (Revised) & |
| 08 03 2025 | Quarterly Results |
| 25 04 2025 | Stock Split & Increase in Authorised Capital & Right Issue of Equity Shares |
| 30 05 2025 | Audited Results |
| 14 08 2025 | Quarterly Results |
| 19 08 2025 | Quarterly Results |
| 22 08 2025 | Quarterly Results |
| 30 08 2025 | (Cancelled) |
| 02 09 2025 | Inter alia due to the non-availability of Directors, the meeting of the Board of Directors, which was originally scheduled to be held on Saturday, 30th August, 2025, stands postponed. The said meeting has now been rescheduled and will be held on Tuesday, 02nd September, 2025, inter alia, to consider and transact the following business: 1. Raising of funds by way of issuance of equity shares or any other eligible securities (?Securities?) through permissible modes, including but not limited to a private placement, right issue, a qualified institutions placement, preferential issue, or any other method or combination of methods as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required and the approval of shareholders of the Company. 2. Discussion on proposal relating to a potential acquisition of entities. The said acquisition, if approved by the Board, would be subject to the execution of definitive agreements and fulfillment of applicable statutory and regulatory requirements. 3. Convening of a Shareholders? Meeting (General Meeting / Postal Ballot), to seek approval of the shareholders for fund-raising. 4. Any other items as may be decided by the Board of Directors of the Company. |
| 14 11 2025 | Quarterly Results |
| 16 12 2025 | Rights Issue & Right Issue of Equity Shares |
| 06 04 2026 | Quarterly Results & Inter alia, to consider and approve inter alia, the following agendas: 1. Raising of funds by way of issuance of equity shares or any other eligible securities (?Securities?) through permissible modes, including but not limited to a private placement, right issue, a qualified institutions placement, preferential issue, or any other method or combination of methods as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required and the approval of shareholders of the Company 2. The Unaudited Financial Results (Standalone) of the Company for the quarter ended 31st December, 2025. 3. Any other items as may be decided by the Board of Directors of the Company |
| 07 04 2026 | Quarterly Results & The meeting of the Board of Directorsof the Company which was originally scheduled to be held on Monday, 06th April, 2026, has beenpostponed. The said meeting has now been rescheduled to Tuesday, 07th April, 2026, inter alia, to transact the following business: 1. Raising of funds by way of issuance of equity shares or any other eligible securities (?Securities?) through permissible modes, including but not limited to a private placement, right issue, a qualified institutions placement, preferential issue, or any other method or combination of methods as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required and the approval of shareholders of the Company. 2. The Unaudited Financial Results (Standalone) of the Company for the quarter ended 31st December, 2025 3. To discuss and consider any other matters with the permission of the Chair, as may be decided by the Board of Directors of the Company. |
